THIER Welcomes Mary Bowie as Independent Non-Executive Director to Strengthen Legal and Compliance
We are pleased to announce the appointment of Mary Bowie to its Board of Directors as an Independent Non-Executive Director, effective September 25, 2024.
THIER, an innovative digital health startup dedicated to preventing lifestyle-related diseases, is pleased to announce the appointment of Mary Bowie to its Board ofDirectors as an Independent Non-Executive Director, effective September 25, 2024.
This appointment signals THIER's commitment to bolstering its governance and strategic direction as it seeks to expand its impact and attract early-stage investors.
MaryBowie brings extensive expertise in legal advisory and governance, honed through leadership roles in prominent organisations within the data analytics and insurance sectors. Currently, as Lead Legal Counsel for the UK at Verisk, aNASDAQ-listed data analytics and solutions provider, Bowie oversees UK legal functions, guiding business stakeholders on complex legal and governance frameworks, policies, and procedures. Her previous roles include Lead LegalCounsel for the UK at Wakam, a dynamic French insurtech company, and over a decade of experience as Senior Legal Counsel at Miller Insurance, an esteemedLloyd's of London specialty insurance broker.
Kofo Mary Are, Senior Executive at THIER, expressed her excitement about Mary’s appointment:
"We are thrilled to welcome Mary Bowie to the THIER Board. Mary brings an exceptional depth of experience from her legal leadership roles in top-tier organisations within financial services and insurance sectors. Her strategic insight and expertise in governance will be invaluable as we position THIER as an investment-ready company."
MaryBowie said "I am honoured to join THIER’s board and support the company’s mission to prevent lifestyle diseases through innovative digital health solutions. I look forward to working closely with THIER’s leadership to advance our shared goals."
About THIER
THIER is an AI-enabled mobile platform focused on preventing obesity and type II diabetes by empowering employers to support healthier employee lifestyles.Designed to cater to Heads of Wellness, Heads of HR, and Heads of OccupationalHealth, THIER provides an actionable suite of tools for organisations across industries such as manufacturing, healthcare, technology, financial services, energy, and transportation.
The platform leverages advanced machine learning algorithms, community-based support, and customised health interventions from healthcare professionals to track, monitor, and prevent the onset of lifestyle diseases within employee populations. All data on THIER’s platform is securely stored on the blockchain, ensuring both data integrity and user privacy.
Learn more about THIER’s mission and solutions:
- 🎥 Watch our introductory video: Link to Video
🤝 Interested in supporting early-stage digital health innovation as an investor? Connect with us here: 👈 😀
Note: THIER holds SEIS and EIS assurance for investor tax benefits.
For further information, please contact: THIER Communications Team
📧 Press@thier.io
***********
The information in this announcement may include forward-looking statements, which are based on the current expectations and projections about future events, and in certain cases can be identified by the use of terms such as "may","will", "should", "expect","anticipate", "project", "estimate","intend", "continue", "target","believe" (or the negatives thereon) or other variations thereon or comparable terminology.
These forward-looking statements, as well as those included in any related materials, are subject to risks, uncertainties and assumptions about the Company and/or its underlying investments, including, among other things, the development of the applicable entity's business, trends in its operating industry, expected use of financing proceeds and future capital expenditures and acquisitions.
Considering these risks, uncertainties and assumptions, the events in the forward-looking statements may not occur.
The information contained in this announcement is given at the date of its publication (unless otherwise marked). No reliance may be placed for any purpose whatsoever on the information or opinions contained in this announcement or on its completeness, accuracy or fairness.
